MeldingsID: 419158
Innsendt dato:
02.02.2017 16:20
UtstederID:
GENT-ME
Utsteder:
Gentian Diagnostics AS
Instrument:
GENT-ME - Gentian Diagnostics
Marked:
MERK
Kategori:
ANDRE MELDINGER
Informasjonspliktig:
Ja
Lagringspliktig:
Nei
Vedlegg:
Tittel:
GENTIAN DIAGNOSTICS - REGISTRATION OF SHARE
CAPITAL INCREASE IN THE NORWEGIAN REGISTER
OF BUSINESS ENTERPRISES
Meldingstekst:
Oslo, 2 February 2017
Reference is made to the stock exchange announcement
following the extraordinary general meeting in Gentian
Diagnostics AS (the "Company) held on 30 January 2017
(the "EGM"). The extraordinary general meeting
approved a private placement (the "Private Placement")
comprising 2,857,143 new shares, each with par value
of NOK 0.10.
The share capital increase pertaining to the Private
Placement has been registered in the Norwegian
Register of Business Enterprises today. Following the
registration, the Company's share capital is NOK
1,399,629.30 divided into 13,996,293 shares, each with
a par value of NOK 0.10. The new shares have been
issued on the Company's ordinary ISIN and are tradable
on Merkur Market.
For more information, please contact:
Julie Alling Gryga
CFO, Gentian Diagnostics
E-mail: [email protected]
Cell Phone: +47 472 62 628
1
Utskriftsdato 06.02.2017